Stay updated on BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial
Sign up to get notified when there's something new on the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page.

Latest updates to the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0, indicating a software version change.SummaryDifference0.0%

- Check16 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2; the previous revision tag was removed.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.4.1 is now displayed on the page, replacing the previous Revision: v3.4.0.SummaryDifference0.0%

- Check59 days agoChange DetectedA glossary toggle labeled 'Show glossary' was added and a new revision tag 'Revision: v3.4.0' is displayed. The status lines now read 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', replacing the previous lowercase variants.SummaryDifference0.2%

- Check73 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

Stay in the know with updates to BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page.